Mergers and Acquisitions
搜索文档
Japan’s biggest banks among firms eyeing India for growth
BusinessLine· 2025-12-17 12:25
Japanese companies are expanding in India, making it one of the busiest corridors for dealmaking in Asia, particularly in financial services. Just Wednesday, Mizuho Financial Group Inc. said it is buying a controlling stake in KKR & Co.-backed investment bank Avendus Capital Pvt. Bigger rival Mitsubishi UFJ Financial Group Inc. might invest more than ¥500 billion ($3.2 billion) to buy about 20% of Shriram Finance Ltd., people familiar with the matter said earlier this week. Sumitomo Mitsui Financial Group ...
Vireo Growth Inc. Enters into Definitive Agreement to Acquire Certain Assets of PharmaCann Inc.
Globenewswire· 2025-12-17 10:03
交易概述 - 公司宣布已签订资产购买协议,收购PharmaCann Inc在科罗拉多州的特定零售资产和物业 [1] - 交易总对价约为4900万美元,将以公司次级投票股支付,并承担部分负债 [2] - 交易预计在2026年上半年完成,需满足交割条件及获得州和地方监管批准 [1][2] 交易战略与影响 - 此次收购将增加17家药房,使公司在科罗拉多州的成人使用零售市场总活跃药房数量达到41家 [1] - 交易进一步优化了公司在科罗拉多州的运营布局,并巩固了其在科罗拉多零售市场的领导地位 [1] - 首席执行官表示,此次交易反映了公司通过增值并购持续发展业务的战略延续,并将与公司在科罗拉多州近期收购的其他资产形成互补 [3] 交易条款与安排 - 股权对价将根据被收购药房的库存水平、应付账款以及截至交割日发生的其他特定事件进行调整 [2] - 股权对价将遵循加拿大证券法下的常规转售限制以及加拿大证券交易所规则的持有期 [2] - 公司一家子公司已与卖方签订管理服务协议,在获得必要监管批准后,将在交割前为被收购药房提供运营管理服务 [2] 公司背景 - 公司成立于2014年,是一家开创性的医用大麻公司 [3] - 公司致力于在行业内建立一个有纪律、战略统一且注重执行的平台,战略核心是强烈的本地市场聚焦与全国投资组合优势相结合 [3]
Berkshire Hathaway vs. MetLife: Which Insurance Giant Stands Out?
ZACKS· 2025-12-17 02:16
Key Takeaways Berkshire's insurance float hit $176B in Q3 2025, backed by strong investments and financial flexibility.MET's New Frontier strategy targets cost cuts, global growth and AI-driven operational efficiency.MET boasts 21% ROE and 2025 EPS growth estimate of 7.2%, topping BRK.B's 7.3% ROE and 5.2% EPS decline.The Federal Reserve, in its latest meeting, cut interest rates for the third time in 2025, and there is a probability of one more next year. Meanwhile, equity markets continue to perform satis ...
Canadian Proxy World Heating Up: Goodmans Partner Jon Feldman, Live at NYSE
Yahoo Finance· 2025-12-17 01:06
CorpGov hosted a fireside chat on Dec. 9 from the floor of the New York Stock Exchange with Jon Feldman, Partner and Business Law Group Head at Goodmans LLP. The in-person interview was joined by Editor-in-Chief John Jannarone and they discussed the current Canadian proxy space, why there have been numerous take-private transactions, and more. Watch the full interview below, or click HERE: About Jon Feldman Jon Feldman is a partner and heads a business law group at Goodmans. His practice focuses on corp ...
First Nordic and Mawson Complete Merger to Create a Leading Nordic-Focused Gold Development and Exploration Company
Globenewswire· 2025-12-17 00:50
TORONTO, Dec. 16, 2025 (GLOBE NEWSWIRE) -- First Nordic Metals Corp. (TSX-V: FNM, FNSE: FNMC SDB, OTCQX: FNMCF, FRA: HEG0) (“First Nordic” or the “Company”) and Mawson Finland Limited (“Mawson”) (TSX-V: MFL, FRA: PM6) are pleased to announce the successful closing of the previously announced acquisition by First Nordic of all of the issued and outstanding common shares of Mawson (the “Mawson Shares”) by way of a court-approved plan of arrangement under the Business Corporations Act (Ontario) (the “Transacti ...
5 High-Risk, High-Reward Biotech Breakthrough Stocks to Watch in 2026
ZACKS· 2025-12-16 23:26
Key Takeaways Five biotech stocks are highlighted for 2026 due to late-stage trials or upcoming FDA decisions.MindMed expects multiple phase III data readouts in 2026 for its lead program MM120.Ocugen, Kyverna and Celcuity face key inflection points tied to BLAs or pivotal clinical data.After a weak first half, the drug and biotech sector has recovered in the past 2-3 months with large drugmakers like Pfizer, AstraZeneca, Eli Lilly and Novo Nordisk signing drug pricing agreements with the Trump administrati ...
Standard Premium Forecasts 2026 Industry Trends, Market Outlook for Insurance Premium Finance and Performance Objectives Amid Continued Growth
Globenewswire· 2025-12-16 23:02
MIAMI, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Standard Premium Finance Holdings, Inc. (OTCQX: SPFX) (“Standard Premium”), a leading specialty finance company, today shares its perspective on key trends shaping the insurance premium finance market in 2026 and defines performance objectives aligned with its long-term growth strategy. Standard Premium has expanded its operating footprint to 40 licensed states and more than doubled its available capital through a recently expanded $115 million credit facility, posit ...
AI megadeals, IPO green shoots, and a middle-market squeeze: The new M&A reality for CFOs
Fortune· 2025-12-16 21:06
Good morning. M&A made a comeback this year, but growth is lagging in the middle market.PwC’s U.S. Deals 2026 Outlook, released this morning, credits the AI boom and a revitalized private equity (PE) activity for the market achieving 10,333 deals worth $1.6 trillion through Nov. 30, 2025. Total deal value rose about 45% from last year and was the second-highest ever recorded, even amid major shifts in economic policy, such as tariffs.Courtesy of PwCBig bets on AI helped drive activity among tech companies—e ...
Zacks Industry Outlook UnitedHealth, Humana and Centene
ZACKS· 2025-12-16 18:01
文章核心观点 - 美国健康维护组织行业正面临医疗成本上升和监管压力等挑战 但通过战略并购和技术创新 行业公司仍在寻求扩张和提升竞争力 联合健康集团、哈门那及Centene公司凭借其业务模式和发展战略 被视为能够抵御行业逆风的标的 [1][3][20] 行业定义与商业模式 - 行业由为订阅者提供基本及补充健康服务的实体构成 主要业务是承担风险并为健康和医疗保险政策设定保费 同时也为自筹资金保险提供行政和托管护理服务 [4] - 服务通常通过由初级保健医生、临床设施、医院和专家组成的认可护理提供商网络提供 紧急或必要时可使用网络外服务 健康保险计划可通过私人购买、社会保险或社会福利计划获得 [5] 塑造行业未来的四大趋势 医疗费用上升 - 医疗成本因多种因素攀升 包括先前推迟的医疗护理、常规筛查和慢性病管理的恢复 导致医疗利用率增加和保险索赔激增 处方药成本也持续急剧上升 [6] - 人口老龄化以及肥胖相关糖尿病和心血管疾病等慢性病发病率上升 进一步加剧了长期成本压力 这些动态因素拉高了健康收益比率 从而压缩了利润率 [7] 监管挑战 - 国内市场的健康保险公司正面临监管不确定性增加的时期 立法提案可能降低医疗补助的联邦资金、引入工作要求并收紧资格验证 这些措施可能降低覆盖水平并压缩提供商和保险公司的报销率 [8] - 医疗保险优惠支付费率调整以及《平价医疗法案》下强制覆盖范围的潜在缩减也带来了不确定性 医疗补助和医疗保险支付的减少可能将本已微薄的利润率推至亏损 此外 ACA补贴的减少可能会抑制市场计划的参保人数 [9] - 鉴于商业保险产品通常比医疗补助或ACA计划提供更高的利润率 保险公司越来越优先考虑扩大其商业产品组合 不过 预计2026年医疗保险优惠费率的提高可能会提供一些利润率支持 [10] 医疗专业人员短缺 - 全国范围内护士和其他医疗专业人员的持续短缺继续困扰医院运营 尤其是在患者数量增加的情况下 推动此危机的关键因素包括护理人员老龄化、普遍的职业倦怠以及劳动力分布不均 [11] - HMO公司与医院、医生和其他提供商合作 为其会员提供具有成本效益的护理 这些服务的质量和可靠性对于维持客户满意度和续订健康计划至关重要 然而 护理人员的减少可能会损害医院提供高质量护理的能力 最终影响客户保留率和HMO公司的声誉 [12] 对并购的战略重视 - 除了利用技术进步 HMO公司经常进行并购以增强其能力、渗透新市场、巩固在现有地区的地位、扩大客户群并加强其全国影响力 这些战略举措也促进了多元化 使公司能够保持竞争优势 [13] - 随着美联储宣布2025年进行三次降息并暗示2026年将进一步降息 借贷成本预计将下降 这种更有利的利率环境可能会鼓励并购活动 因为行业参与者能够以更低的成本获得融资 从而最大限度地减少耗尽内部现金储备的需要 [14] 行业排名与市场表现 - 该行业的Zacks行业排名为第212位 处于所有250多个Zacks行业中的后12% 这表明其近期前景平淡 行业排名靠后是成分公司总体盈利前景负面所致 [15][16] - 在过去一年中 Zacks医疗-HMO行业下跌了25.8% 而同期Zacks标普500综合指数增长了2.4% Zacks医疗板块则上涨了14.3% [18] 行业估值 - 基于常用于医疗股估值的未来12个月市盈率 该行业的交易倍数为16.04倍 而标普500指数为23.35倍 医疗板块为20.92倍 在过去五年中 该行业的市盈率最高为19.57倍 最低为11.58倍 中位数为16.2倍 [19] 值得关注的三只股票 联合健康集团 - 公司的收入得益于联合健康保险和Optum的强劲表现 联合健康保险部门受益于有效的医疗保险和医疗补助产品 整合了可负担且有吸引力的功能 从而扩大了会员人数并增加了保费收入 这为公司赢得了多个合同 Optum的增长则由收购、先进技术和数据驱动的护理模式推动 战略性并购和远程医疗投资进一步增强了UNH的全国覆盖范围和服务效率 [21] - Zacks对联合健康集团2025年每股收益的共识预期为16.29美元 收入共识预期意味着较上年增长11.9% 在过去四个季度中 UNH的收益两次超出预期 两次未达预期 平均负意外为2.25% [22] 哈门那 - 公司保持了由保费上涨和会员基础扩大推动的稳定增长 这些计划的强劲表现为公司赢得了多个新的州政府机构合同 通过其CenterWell品牌 哈门那继续专注于满足美国老年人口的医疗保健需求 多年来 公司还进行了战略性收购 从而拓宽了其收入来源 [23] - Zacks对哈门那2025年每股收益的共识预期为17.08美元 表明较2024年数字增长5.4% 2025年收入共识预期意味着较2024年数字增长10% 在过去四个季度中 HUM的收益三次超出预期 一次未达预期 平均正意外为7.54% [24] Centene - 公司的收入增长得益于其医疗保险和医疗补助业务的强劲表现 这促成了合同赢得数量的增加和会员人数的扩大 美国老龄化人口对医疗保险优惠计划的持续偏好 继续推动对Centene医疗保险产品的稳定需求 公司推行无机增长战略 利用战略性收购以及与医疗保健提供商的合作来拓宽其能力 [25] - Zacks对Centene 2025年每股收益的共识预期为2.00美元 2025年收入共识预期意味着较2024年数字增长18.5% 在过去四个季度中 CNC的收益三次超出预期 一次未达预期 平均正意外为75.18% [26]
Warner Bros. is blockbuster finale to $4.5 trillion M&A haul
Fortune· 2025-12-16 07:27
Dealmakers are heading into the final weeks of 2025 on a $100 billion cliffhanger.Paramount Skydance Corp.’s hostile bid to snatch Warner Bros. Discovery Inc. from under the nose of Netflix Inc. encapsulates the themes that have shaped a banner year for mergers and acquisitions: renewed desire for transformative tie-ups, massive checks from Wall Street, the flow of Middle East money and US President Donald Trump’s role as both disruptor and dealmaker.Global transaction values have risen around 40% to about ...